Skip to menu Skip to content Skip to footer

Phase 2 clinical study for a next-generation, needle free COVID-19 vaccine CRC-P administered by Vaxxas Pty Ltd) (2023-2025)

Experts

Associate Professor David Muller

Principal Research Fellow
School of Chemistry and Molecular Biosciences
Faculty of Science
David Muller
David Muller